Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.
Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, Guardalben E, Liberatore C, Faraci D, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A. Rigolin GM, et al. Among authors: melandri a. Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26. Blood. 2017. PMID: 28446433 Free article. No abstract available.
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM, Formigaro L, Cavallari M, Quaglia FM, Lista E, Urso A, Guardalben E, Martinelli S, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A. Rigolin GM, et al. Among authors: melandri a. Oncotarget. 2017 Apr 25;8(17):28008-28020. doi: 10.18632/oncotarget.15883. Oncotarget. 2017. PMID: 28427204 Free PMC article.
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
Rigolin GM, Saccenti E, Guardalben E, Cavallari M, Formigaro L, Zagatti B, Visentin A, Mauro FR, Lista E, Bassi C, Lupini L, Quaglia FM, Urso A, Bardi MA, Bonaldi L, Volta E, Tammiso E, Ilari C, Cafforio L, Melandri A, Cavazzini F, Negrini M, Semenzato G, Trentin L, Foà R, Cuneo A. Rigolin GM, et al. Among authors: melandri a. Br J Haematol. 2018 Apr;181(2):229-233. doi: 10.1111/bjh.15174. Epub 2018 Apr 2. Br J Haematol. 2018. PMID: 29611195 Free article.
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
Rigolin GM, Saccenti E, Melandri A, Cavallari M, Urso A, Rotondo F, Betulla A, Tognolo L, Bardi MA, Rossini M, Tammiso E, Bassi C, Cavazzini F, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: melandri a. Br J Haematol. 2021 Mar;192(6):1068-1072. doi: 10.1111/bjh.16865. Epub 2020 Jun 24. Br J Haematol. 2021. PMID: 32578873 Free article. Clinical Trial.
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM, Saccenti E, Bassi C, Lupini L, Quaglia FM, Cavallari M, Martinelli S, Formigaro L, Lista E, Bardi MA, Volta E, Tammiso E, Melandri A, Urso A, Cavazzini F, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: melandri a. J Hematol Oncol. 2016 Sep 15;9(1):88. doi: 10.1186/s13045-016-0320-z. J Hematol Oncol. 2016. PMID: 27633522 Free PMC article.
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia.
Cavallari M, Cavazzini F, Bardi A, Volta E, Melandri A, Tammiso E, Saccenti E, Lista E, Quaglia FM, Urso A, Laudisi M, Menotti E, Formigaro L, Dabusti M, Ciccone M, Tomasi P, Negrini M, Cuneo A, Rigolin GM. Cavallari M, et al. Among authors: melandri a. Oncotarget. 2018 Sep 28;9(76):34398-34412. doi: 10.18632/oncotarget.26146. eCollection 2018 Sep 28. Oncotarget. 2018. PMID: 30344950 Free PMC article. Review.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A. Rigolin GM, et al. Among authors: melandri a. Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883. Blood. 2021. PMID: 34587233 Free article. Clinical Trial. No abstract available.
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM, Saccenti E, Bassi C, Lupini L, Quaglia FM, Cavallari M, Martinelli S, Formigaro L, Lista E, Bardi MA, Volta E, Tammiso E, Melandri A, Urso A, Cavazzini F, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: melandri a. J Hematol Oncol. 2016 Sep 30;9(1):103. doi: 10.1186/s13045-016-0331-9. J Hematol Oncol. 2016. PMID: 27716358 Free PMC article. No abstract available.
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells.
Casari G, Dall'Ora M, Melandri A, Masciale V, Chiavelli C, Prapa M, Neri G, Spano MC, Murgia A, D'Esposito A, Baschieri MC, Ceccherelli GB, Dominici M, Grisendi G. Casari G, et al. Among authors: melandri a. Cytotherapy. 2023 Jun;25(6):605-614. doi: 10.1016/j.jcyt.2023.02.008. Epub 2023 Apr 1. Cytotherapy. 2023. PMID: 37012089 Free article.
Observation of inverse Compton emission from a long γ-ray burst.
MAGIC Collaboration; Veres P, Bhat PN, Briggs MS, Cleveland WH, Hamburg R, Hui CM, Mailyan B, Preece RD, Roberts OJ, von Kienlin A, Wilson-Hodge CA, Kocevski D, Arimoto M, Tak D, Asano K, Axelsson M, Barbiellini G, Bissaldi E, Dirirsa FF, Gill R, Granot J, McEnery J, Omodei N, Razzaque S, Piron F, Racusin JL, Thompson DJ, Campana S, Bernardini MG, Kuin NPM, Siegel MH, Cenko SB, O'Brien P, Capalbi M, Daì A, De Pasquale M, Gropp J, Klingler N, Osborne JP, Perri M, Starling RLC, Tagliaferri G, Tohuvavohu A, Ursi A, Tavani M, Cardillo M, Casentini C, Piano G, Evangelista Y, Verrecchia F, Pittori C, Lucarelli F, Bulgarelli A, Parmiggiani N, Anderson GE, Anderson JP, Bernardi G, Bolmer J, Caballero-García MD, Carrasco IM, Castellón A, Segura NC, Castro-Tirado AJ, Cherukuri SV, Cockeram AM, D'Avanzo P, Di Dato A, Diretse R, Fender RP, Fernández-García E, Fynbo JPU, Fruchter AS, Greiner J, Gromadzki M, Heintz KE, Heywood I, van der Horst AJ, Hu YD, Inserra C, Izzo L, Jaiswal V, Jakobsson P, Japelj J, Kankare E, Kann DA, Kouveliotou C, Klose S, Levan AJ, Li XY, Lotti S, Maguire K, Malesani DB, Manulis I, Marongiu M, Martin S, Melandri A, Michałowski MJ, Miller-Jones JCA, Misra K, Mo… See abstract for full author list ➔ MAGIC Collaboration, et al. Among authors: melandri a. Nature. 2019 Nov;575(7783):459-463. doi: 10.1038/s41586-019-1754-6. Epub 2019 Nov 20. Nature. 2019. PMID: 31748725 Free article.
28 results